相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Determination of Binding Sites on Trastuzumab and Pertuzumab to Selective Affimers Using Hydrogen-Deuterium Exchange Mass Spectrometry
Oladapo Olaleye et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2023)
Accurate and rapid microfluidic ELISA to monitor Infliximab titers in patients with inflammatory bowel diseases
Ines Iria et al.
ANALYST (2022)
Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings
Po-Hung Hsieh et al.
NPJ BREAST CANCER (2022)
Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases
Henry Ordutowski et al.
BIOSENSORS & BIOELECTRONICS (2022)
Selection and characterisation of Affimers specific for CEA recognition
Shazana Hilda Shamsuddin et al.
SCIENTIFIC REPORTS (2021)
Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology
Etienne Chatelut et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)
Recombinant Peptide Mimetic NanoLuc Tracer for Sensitive Immunodetection of Mycophenolic Acid
Alvaro Luque-Uria et al.
ANALYTICAL CHEMISTRY (2021)
Engineering Protein Switches for Rapid Diagnostic Tests
Hope Adamson et al.
ACS SENSORS (2020)
Rapid, Cost-Effective Peptide/Nucleic Acid-Based Platform for Therapeutic Antibody Monitoring in Clinical Samples
Marco Mocenigo et al.
ACS SENSORS (2020)
Point-of-Care Therapeutic Drug Monitoring for Precision Dosing of Immunosuppressive Drugs
Adriano Taddeo et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
Generalizable Protein Biosensors Based on Synthetic Switch Modules
Zhong Guo et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Product Design: Enzymatic Biosensors for Body Fluid Analysis
Zhiling Zhang et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2019)
Phage Display in the Quest for New Selective Recognition Elements for Biosensors
Riikka Peltomaa et al.
ACS OMEGA (2019)
Affimers as anti-idiotypic affinity reagents for pharmacokinetic analysis of biotherapeutics
Hope Adamson et al.
BIOTECHNIQUES (2019)
Affimer-Enzyme-Inhibitor Switch Sensor for Rapid Wash-free Assays of Multimeric Proteins
Hope Adamson et al.
ACS SENSORS (2019)
Noncompetitive homogeneous immunodetection of small molecules based on beta-glucuronidase complementation
Jiulong Su et al.
ANALYST (2018)
Dual-Color Bioluminescent Sensor Proteins for Therapeutic Drug Monitoring of Antitumor Antibodies
Martijn van Rosmalen et al.
ANALYTICAL CHEMISTRY (2018)
Programmable Nucleic Acid Nanoswitches for the Rapid, Single-Step Detection of Antibodies in Bodily Fluids
Alessandro Porchetta et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Sizheng Zhao et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Development and validation of an optical biosensor for rapid monitoring of adalimumab in serum of patients with Crohn's disease
Sumin Bian et al.
DRUG TESTING AND ANALYSIS (2018)
Affimers proteins are versatile and renewable affinity reagents
Christian Tiede et al.
ELIFE (2017)
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
Fanny Huynh Du et al.
AUTOIMMUNITY HIGHLIGHTS (2017)
Population pharmacokinetic and exposure-response analysis for trastuzumab administered using a subcutaneous manual syringe injection or intravenously in women with HER2-positive early breast cancer
Angelica L. Quartino et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory and Malignant Disease: Translating TNF-α Experience to Oncology
T. H. Oude Munnink et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Modular protein switches derived from antibody mimetic proteins
N. Nicholes et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
Detection of Antibodies in Blood Plasma Using Bioluminescent Sensor Proteins and a Smartphone
Remco Arts et al.
ANALYTICAL CHEMISTRY (2016)
Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits
Ellen M. H. Schmitz et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care
S. Chevaliez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Therapeutic drug monitoring in inflammatory bowel disease
Jacqueline Jossen et al.
CURRENT OPINION IN PEDIATRICS (2016)
Direct Oral Anticoagulants Monitoring Anticoagulant Effect
Barbara A. Konkle
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2016)
Quantification of active infliximab in human serum with liquid chromatography-tandem mass spectrometry using a tumor necrosis factor alpha-based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method
Mohsin El Amrani et al.
JOURNAL OF CHROMATOGRAPHY A (2016)
Engineered PQQ-Glucose Dehydrogenase as a Universal Biosensor Platform
Zhong Guo et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels
Meghna Jani et al.
RHEUMATOLOGY (2016)
Model-based clinical pharmacology profiling of ipilimumab in patients with advanced melanoma
Yan Feng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Review of therapeutic drug monitoring of anticancer drugs part 1-Cytotoxics
Angelo Paci et al.
EUROPEAN JOURNAL OF CANCER (2014)
A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes
Bo Zhang et al.
NATURE MEDICINE (2014)
Switchable Reporter Enzymes Based on Mutually Exclusive Domain Interactions Allow Antibody Detection Directly in Solution
Sambashiva Banala et al.
ACS CHEMICAL BIOLOGY (2013)
Exposure-Response Relationships of the Efficacy and Safety of Ipilimumab in Patients with Advanced Melanoma
Yan Feng et al.
CLINICAL CANCER RESEARCH (2013)
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy
Valentina Ciravolo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
Evan J. Lipson et al.
CLINICAL CANCER RESEARCH (2011)
Antibody Detection by Using a FRET-Based Protein Conformational Switch
Misha V. Golynskiy et al.
CHEMBIOCHEM (2010)
Structure-switching biosensors: inspired by Nature
Alexis Vallee-Belisle et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2010)
Intensive Loading Dose of Trastuzumab Achieves Higher-Than-Steady-State Serum Concentrations and Is Well Tolerated
Brian Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
The bioanalysis of the monoclonal antibody trastuzumab by high-performance liquid chromatography with fluorescence detection after immuno-affinity purification from human serum
Carola W. N. Damen et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Clinical Pharmacology of Trastuzumab
Dominique Leveque et al.
CURRENT CLINICAL PHARMACOLOGY (2008)
Assay development and screening of a serine/threonine kinase in an on-chip mode using caliper nanofluidics technology
Dominique Perrin et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
GJ Wolbink et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
In vitro assays for the diagnosis of IgE-mediated disorders
RG Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
MR Smith
ONCOGENE (2003)
Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum
LSW Steijns et al.
THERAPEUTIC DRUG MONITORING (2002)